388 related articles for article (PubMed ID: 33282862)
1. Histone Deacetylases (HDACs) and Atherosclerosis: A Mechanistic and Pharmacological Review.
Chen X; He Y; Fu W; Sahebkar A; Tan Y; Xu S; Li H
Front Cell Dev Biol; 2020; 8():581015. PubMed ID: 33282862
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylases and atherosclerosis.
Zheng XX; Zhou T; Wang XA; Tong XH; Ding JW
Atherosclerosis; 2015 Jun; 240(2):355-66. PubMed ID: 25875381
[TBL] [Abstract][Full Text] [Related]
3. Posttranslational modifications of histone deacetylases: implications for cardiovascular diseases.
Eom GH; Kook H
Pharmacol Ther; 2014 Aug; 143(2):168-80. PubMed ID: 24594235
[TBL] [Abstract][Full Text] [Related]
4. New Insight in HDACs: Potential Therapeutic Targets for the Treatment of Atherosclerosis.
Luan Y; Liu H; Luan Y; Yang Y; Yang J; Ren KD
Front Pharmacol; 2022; 13():863677. PubMed ID: 35529430
[TBL] [Abstract][Full Text] [Related]
5. Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis.
Zhou B; Margariti A; Zeng L; Xu Q
Cardiovasc Res; 2011 Jun; 90(3):413-20. PubMed ID: 21233251
[TBL] [Abstract][Full Text] [Related]
6. Atherosclerosis and flow: roles of epigenetic modulation in vascular endothelium.
Lee DY; Chiu JJ
J Biomed Sci; 2019 Aug; 26(1):56. PubMed ID: 31387590
[TBL] [Abstract][Full Text] [Related]
7. The role of class IIa histone deacetylases in regulating endothelial function.
Shen Z; Bei Y; Lin H; Wei T; Dai Y; Hu Y; Zhang C; Dai H
Front Physiol; 2023; 14():1091794. PubMed ID: 36935751
[TBL] [Abstract][Full Text] [Related]
8. Critical Functions of Histone Deacetylases (HDACs) in Modulating Inflammation Associated with Cardiovascular Diseases.
Kulthinee S; Yano N; Zhuang S; Wang L; Zhao TC
Pathophysiology; 2022 Aug; 29(3):471-485. PubMed ID: 35997393
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylases and cardiovascular cell lineage commitment.
Yang JY; Wang Q; Wang W; Zeng LF
World J Stem Cells; 2015 Jun; 7(5):852-8. PubMed ID: 26131315
[TBL] [Abstract][Full Text] [Related]
10. Cystathionine γ-lyase protects vascular endothelium: a role for inhibition of histone deacetylase 6.
Leucker TM; Nomura Y; Kim JH; Bhatta A; Wang V; Wecker A; Jandu S; Santhanam L; Berkowitz D; Romer L; Pandey D
Am J Physiol Heart Circ Physiol; 2017 Apr; 312(4):H711-H720. PubMed ID: 28188215
[TBL] [Abstract][Full Text] [Related]
11. Targeting histone deacetylases: perspectives for epigenetic-based therapy in cardio-cerebrovascular disease.
Wang ZY; Qin W; Yi F
J Geriatr Cardiol; 2015 Mar; 12(2):153-64. PubMed ID: 25870619
[TBL] [Abstract][Full Text] [Related]
12. Expression of Class I Histone Deacetylases in Ipsilateral and Contralateral Hemispheres after the Focal Photothrombotic Infarction in the Mouse Brain.
Demyanenko S; Neginskaya M; Berezhnaya E
Transl Stroke Res; 2018 Oct; 9(5):471-483. PubMed ID: 29218547
[TBL] [Abstract][Full Text] [Related]
13. Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy.
Verza FA; Das U; Fachin AL; Dimmock JR; Marins M
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32585896
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in class IIa histone deacetylases research.
Asfaha Y; Schrenk C; Alves Avelar LA; Hamacher A; Pflieger M; Kassack MU; Kurz T
Bioorg Med Chem; 2019 Nov; 27(22):115087. PubMed ID: 31561937
[TBL] [Abstract][Full Text] [Related]
15. A class of their own: exploring the nondeacetylase roles of class IIa HDACs in cardiovascular disease.
Wright LH; Menick DR
Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H199-206. PubMed ID: 27208161
[TBL] [Abstract][Full Text] [Related]
16. Roles of HDACs in the Responses of Innate Immune Cells and as Targets in Inflammatory Diseases.
Hu Y; Suliman BA
Adv Exp Med Biol; 2017; 1024():91-110. PubMed ID: 28921466
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylases function as novel potential therapeutic targets for cancer.
Zhang H; Shang YP; Chen HY; Li J
Hepatol Res; 2017 Feb; 47(2):149-159. PubMed ID: 27457249
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory selectivity among class I HDACs has a major impact on inflammatory gene expression in macrophages.
Cao F; Zwinderman MRH; van Merkerk R; Ettema PE; Quax WJ; Dekker FJ
Eur J Med Chem; 2019 Sep; 177():457-466. PubMed ID: 31181405
[TBL] [Abstract][Full Text] [Related]
19. Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitors.
Galán M; Varona S; Orriols M; Rodríguez JA; Aguiló S; Dilmé J; Camacho M; Martínez-González J; Rodriguez C
Dis Model Mech; 2016 May; 9(5):541-52. PubMed ID: 26989193
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of histone deacetylases in cancer.
Montezuma D; Henrique RM; Jerónimo C
Crit Rev Oncog; 2015; 20(1-2):19-34. PubMed ID: 25746102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
